Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |